{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:10:51Z","timestamp":1761750651970,"version":"build-2065373602"},"reference-count":163,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jiph.2020.11.009","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T07:16:28Z","timestamp":1607325388000},"page":"24-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of repurposed drugs on the symptomatic COVID-19 patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Iqbal","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-2557","authenticated-orcid":false,"given":"Afzal","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed F.","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-900X","authenticated-orcid":false,"given":"Md. Tabish","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2020.11.009_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","volume":"41","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jiph.2020.11.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102442","article-title":"Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy","volume":"109","author":"Ceribelli","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jiph.2020.11.009_bib0015","unstructured":"COVID-19 Situation Update Worldwide, as of 6 October 2020 n.d. https:\/\/www.ecdc.europa.eu\/en\/geographical-distribution-2019-ncov-cases [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0020","unstructured":"Advice for Public n.d. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public?gclid=Cj0KCQjwlN32BRCCARIsADZ-J4scnLfOt5TRY6NUf3VhGxhC_YPEgmDgch4o1Vo0VhfK7c5XbAv2xlsaAh5CEALw_wcB [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10937404.2020.1752340","article-title":"Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review","volume":"23","author":"Pereira","year":"2020","journal-title":"J Toxicol Environ Heal B"},{"key":"10.1016\/j.jiph.2020.11.009_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2020.11.009_bib0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jmv.25707","article-title":"Potential interventions for novel coronavirus in China: a systematic review","volume":"92","author":"Zhang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0050","doi-asserted-by":"crossref","DOI":"10.1007\/s12250-020-00204-7","article-title":"Old weapon for new enemy: drug repurposing for treatment of newly emerging viral diseases","author":"Guo","year":"2020","journal-title":"Virol Sin"},{"key":"10.1016\/j.jiph.2020.11.009_bib0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","article-title":"Treatment options for COVID-19: the reality and challenges","volume":"53","author":"Jean","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jiph.2020.11.009_bib0060","article-title":"Controversial treatments: an updated understanding of the coronavirus disease 2019","author":"Zhang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0065","unstructured":"Cases in the U.S. | CDC n.d. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/cases-in-us.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcases-in-us.html [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2020.11.009_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nurpra.2020.03.021","article-title":"Corona virus 101","author":"Holstein","year":"2020","journal-title":"J Nurse Pract"},{"key":"10.1016\/j.jiph.2020.11.009_bib0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2020.11.009_bib0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0095","doi-asserted-by":"crossref","first-page":"105951","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2020.11.009_bib0100","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.7560","article-title":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19)","author":"Kakodkar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jiph.2020.11.009_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2169-0","article-title":"Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins","author":"Lam","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2020.11.009_bib0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/v12010083","article-title":"A tale of two viruses: the distinct Spike Glycoproteins of feline coronaviruses","volume":"12","author":"Jaimes","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2020.11.009_bib0115","first-page":"94","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0120","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/S0140-6736(20)30313-5","article-title":"2019-nCoV transmission through the ocular surface must not be ignored","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/rccm.2014P7","article-title":"Novel Wuhan (2019-nCoV) coronavirus","volume":"201","author":"Carlos","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jmv.25725","article-title":"Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS\u2010CoV\u20102 infection","volume":"92","author":"Xia","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0135","article-title":"The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes","author":"Zhang","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jiph.2020.11.009_bib0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cmrp.2020.04.001","article-title":"An overview of coronaviruses including the SARS-2 coronavirus\u2013molecular biology, epidemiology and clinical implications","volume":"10","author":"Kaul","year":"2020","journal-title":"Curr Med Res Pract"},{"key":"10.1016\/j.jiph.2020.11.009_bib0145","unstructured":"How Coronavirus Spreads | CDC n.d. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/how-covid-spreadshtml?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Ftransmission.html [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0150","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0155","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2020.11.009_bib0160","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"year":"2020","series-title":"Incidence, Clinical Characteristics and Prognostic Factor of Patients with COVID-19: a Systematic Review and Meta-Analysis","author":"Zhao","key":"10.1016\/j.jiph.2020.11.009_bib0165"},{"key":"10.1016\/j.jiph.2020.11.009_bib0170","article-title":"Clinical and laboratory factors predicting the prognosis of patients with COVID-19: an analysis of 127 patients in Wuhan, China","author":"Bai","year":"2020","journal-title":"SSRN Electron J"},{"key":"10.1016\/j.jiph.2020.11.009_bib0175","article-title":"A simple laboratory parameter facilitates early identification of COVID-19 patients","author":"Li","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jiph.2020.11.009_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2020.104058","article-title":"Clinical characteristics of older patients infected with COVID-19: a descriptive study","volume":"89","author":"Niu","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jiph.2020.11.009_bib0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijsu.2020.04.001","article-title":"Evidence based management guideline for the COVID-19 pandemic-review article","volume":"77","author":"Nicola","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.jiph.2020.11.009_bib0190","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jinf.2020.03.005","article-title":"Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients","volume":"80","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2020.11.009_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.051","article-title":"Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients","author":"Pan","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2020.11.009_bib0200","article-title":"Evaluation of enzyme-linked immunoassay and colloidal gold- immunochromatographic assay kit for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19)","author":"Xiang","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jiph.2020.11.009_bib0205","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID\u201019) implicate special control measures","volume":"92","author":"Wang","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0210","article-title":"Development and clinical application of a rapid IgM\u2010IgG combined antibody test for SARS-CoV-2 infection diagnosis","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.dsx.2020.04.011","article-title":"COVID-19: from bench to bed side","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.jiph.2020.11.009_bib0220","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","author":"Guo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jinf.2015.07.002","article-title":"Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection","volume":"71","author":"Gao","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2020.11.009_bib0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0235","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2020.11.009_bib0240","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.2020.1623","article-title":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China","volume":"323","author":"Chang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2020.11.009_bib0245","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020200236","article-title":"CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia","volume":"295","author":"Lei","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jiph.2020.11.009_bib0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clinimag.2020.02.008","article-title":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: the value of CT images in the course of the disease","volume":"63","author":"Lin","year":"2020","journal-title":"Clin Imaging"},{"key":"10.1016\/j.jiph.2020.11.009_bib0255","unstructured":"Coronavirus Disease 2019 n.d. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0260","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJMp2002125","article-title":"Defining the epidemiology of Covid-19 \u2014 studies needed","volume":"382","author":"Lipsitch","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108409","article-title":"Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic","volume":"215","author":"Gasmi","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0270","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/S2214-109X(20)30074-7","article-title":"Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts","volume":"8","author":"Hellewell","year":"2020","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.jiph.2020.11.009_bib0275","first-page":"113","article-title":"Corona virus: global pandemic causing world-wide shutdown","volume":"112","author":"Mitchell","year":"2020","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jiph.2020.11.009_bib0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.jiph.2020.11.009_bib0285","first-page":"3422","article-title":"COVID-19: emerging protective measures","volume":"24","author":"Balachandar","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jiph.2020.11.009_bib0290","doi-asserted-by":"crossref","unstructured":"Fao. Maintaining a Healthy Diet During the COVID-19 Pandemic n.d. https:\/\/doi.org\/10.4060\/ca8380en.","DOI":"10.4060\/ca8380en"},{"key":"10.1016\/j.jiph.2020.11.009_bib0295","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/nu12040988","article-title":"Evidence that vitamin d supplementation could reduce risk of influenza and COVID-19 infections and deaths","volume":"12","author":"Grant","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jiph.2020.11.009_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101647","article-title":"Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of the evidence","author":"Cao","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0305","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6019","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19)","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2020.11.009_bib0310","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0315","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0320","series-title":"Coronaviruses methods protoc.","first-page":"1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","author":"Fehr","year":"2015"},{"key":"10.1016\/j.jiph.2020.11.009_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2014.00296","article-title":"Coronavirus infection, ER stress, apoptosis and innate immunity","volume":"5","author":"Fung","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0330","article-title":"ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection","author":"Fan","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.jiph.2020.11.009_bib0335","unstructured":"COVID-19 Clinical Trials Worldwide by Region May 28, 2020 | Statista n.d. https:\/\/www.statista.com\/statistics\/1106306\/coronavirus-clinical-trials-worldwide\/ [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"10.1016\/j.jiph.2020.11.009_bib0345","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jiph.2020.11.009_bib0350","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","article-title":"Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial","volume":"11","author":"Paton","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0355","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/v10050268","article-title":"Paradoxical effect of chloroquine treatment in enhancing Chikungunya virus infection","volume":"10","author":"Roques","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2020.11.009_bib0360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jiph.2020.11.009_bib0365","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/B:JOCI.0000010424.41475.17","article-title":"Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms","volume":"23","author":"Seitz","year":"2003","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0370","unstructured":"The Protein Tyrosine Kinase p56lck is Required for Triggering NF-kappaB Activation Upon Interaction of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 With Cell Surface CD4-PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/9621091\/ [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0375","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.ijantimicag.2020.105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2020.11.009_bib0380","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jiph.2020.11.009_bib0385","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0390","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dsx.2020.03.011","article-title":"Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.jiph.2020.11.009_bib0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2020.11.009_bib0400","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0601856","article-title":"Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities","volume":"49","author":"Biot","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.jiph.2020.11.009_bib0405","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"year":"2020","series-title":"DHHS Letterhead","author":"Bright","key":"10.1016\/j.jiph.2020.11.009_bib0410"},{"key":"10.1016\/j.jiph.2020.11.009_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2020.11.009_bib0420","article-title":"Pharmacotherapy in COVID-19; a narrative review for emergency providers","author":"Mehta","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2019.158387","article-title":"Toxicokinetics of hydroxychloroquine following a massive overdose","volume":"37","author":"de Olano","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0430","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jiph.2020.11.009_bib0435","first-page":"9","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","author":"Agostini","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.jiph.2020.11.009_bib0440","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiph.2020.11.009_bib0445","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jiph.2020.11.009_bib0450","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiph.2020.11.009_bib0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jiph.2020.11.009_bib0465","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0470","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jmii.2020.03.032","article-title":"Lopinavir\/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan","volume":"53","author":"Cheng","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jiph.2020.11.009_bib0475","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa347","article-title":"A community transmitted case of severe acute respiratory distress syndrome due to SARS CoV2 in the United States","author":"Sanville","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0480","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Japan Acad Ser B"},{"key":"10.1016\/j.jiph.2020.11.009_bib0485","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2020.02.018","article-title":"Discovery and development of safe-in-man broad-spectrum antiviral agents","volume":"93","author":"Andersen","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138277","article-title":"COVID-19: a promising cure for the global panic","volume":"725","author":"Vellingiri","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jiph.2020.11.009_bib0495","unstructured":"Favipiravir Shows Good Clinical Efficacy in Treating COVID-19: Official-Xinhua | English.news.cn n.d. http:\/\/www.xinhuanet.com\/english\/2020-03\/17\/c_138888226.htm [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0500","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1056\/NEJMp030072","article-title":"Managing SARS amidst uncertainty","volume":"348","author":"Wenzel","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0505","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.2003.02391.x","article-title":"Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids","volume":"135","author":"Jones","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0510","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0515","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV\u2013infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0520","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jiph.2020.11.009_bib0525","first-page":"64","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","author":"Martinez","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2020.11.009_bib0530","unstructured":"Mount Sinai Health System Treatment Guidelines for SARS-CoV-2 Infection (COVID-19) 1,2. n.d."},{"key":"10.1016\/j.jiph.2020.11.009_bib0535","unstructured":"The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection-Full Text View-ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04252885 [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0540","unstructured":"Antiviral Activity of Arbidol and Its Derivatives Against the Pathogen of Severe Acute Respiratory Syndrome in the Cell Cultures] - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/18756809\/ [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0545","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.jiph.2020.11.009_bib0550","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S2213-2600(20)30071-0","article-title":"Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics","volume":"8","author":"Zhang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0555","article-title":"Therapeutic management of patients with COVID-19: a systematic review","volume":"2","author":"Tobaiqy","year":"2020","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.jiph.2020.11.009_bib0560","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiph.2020.11.009_bib0565","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jiph.2020.11.009_bib0570","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with Lopinavir\/Ritonavir or Interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0575","article-title":"Molecular modeling evaluation of the binding effect of ritonavir, lopinavir and darunavir to severe acute respiratory syndrome coronavirus 2 proteases","author":"Lin","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jiph.2020.11.009_bib0580","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013Ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0585","unstructured":"Treatment of Severe Acute Respiratory Syndrome with Lopinavir\/Ritonavir: A Multicentre Retrospective Matched Cohort Study - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/14660806\/ [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0590","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMe2005477","article-title":"Covid-19\u2014the search for effective therapy","volume":"382","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0595","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","article-title":"Interferon Alfacon-1 plus corticosteroids in severe acute respiratory syndrome","volume":"290","author":"Loutfy","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jiph.2020.11.009_bib0600","unstructured":"Therapeutic Options for COVID-19 Patients | CDC n.d. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/therapeutic-options.html [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0605","unstructured":"Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04303299 [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0610","doi-asserted-by":"crossref","first-page":"100028","DOI":"10.1016\/j.medidd.2020.100028","article-title":"Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?","volume":"5","author":"Cheng","year":"2020","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.jiph.2020.11.009_bib0615","unstructured":"Shanghai 2019 Expert Coronary Disease Comprehensive Treatment Consensus n.d. https:\/\/mp.weixin.qq.com\/s?__biz=MzA3Nzk5Mzc5MQ==&mid=2653620168&idx=1&sn=2352823b79a3cc42e48229a0c38f65e0&chksm=84962598b3e1ac8effb763e3ddb4858435dc7aa947a8f41790e8df2bca34c20e6ffea64cd191#rd [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0620","unstructured":"High-Dose Vitamin C. (PDQ\u00ae)\u2013Health Professional Version - National Cancer Institute n.d. https:\/\/www.cancer.gov\/about-cancer\/treatment\/cam\/hp\/vitamin-c-pdq [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0625","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0630","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/pds.4428","article-title":"Risk of stroke associated with use of nonsteroidal anti-inflammatory drugs during acute respiratory infection episode","volume":"27","author":"Wen","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jiph.2020.11.009_bib0635","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/infdis\/jiw603","article-title":"Acute respiratory infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: a nationwide case-crossover study","volume":"215","author":"Wen","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiph.2020.11.009_bib0640","first-page":"7","article-title":"The invisible threat of non-steroidal anti-inflammatory drugs for kidneys","author":"Clav\u00e9","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jiph.2020.11.009_bib0645","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0650","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1086","article-title":"Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2020.11.009_bib0655","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0660","unstructured":"WHO Clarifies Guidance on Ibuprofen, Says There\u2019s No Evidence It Can Worsen COVID-19 | CBC News n.d. https:\/\/www.cbc.ca\/news\/health\/ibuprofen-covid-19-novel-coronavirus-1.5501496 [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.03.040","article-title":"Safety of ibuprofen in patients with COVID-19","author":"Sodhi","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jiph.2020.11.009_bib0670","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1185","article-title":"Non-steroidal anti-inflammatory drugs and covid-19","author":"Little","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2020.11.009_bib0675","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chmed.2020.03.004","article-title":"Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection","volume":"12","author":"Liu","year":"2020","journal-title":"Chinese Herb Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0680","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-020-2818-6","article-title":"Treatment of COVID-19: old tricks for new challenges","volume":"24","author":"Cunningham","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jiph.2020.11.009_bib0685","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11655-020-3192-6","article-title":"Can chinese medicine Be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs","volume":"26","author":"Luo","year":"2020","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0690","doi-asserted-by":"crossref","first-page":"8563","DOI":"10.7314\/APJCP.2015.16.18.8563","article-title":"Effect of root extracts of medicinal Herb Glycyrrhiza glabra on HSP90 gene expression and apoptosis in the HT-29 Colon Cancer cell line","volume":"16","author":"Nourazarian","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jiph.2020.11.009_bib0695","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2007.03.003","article-title":"Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle","volume":"75","author":"Keyaerts","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jiph.2020.11.009_bib0700","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jphp.12669","article-title":"A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms","volume":"69","author":"Amber","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jiph.2020.11.009_bib0705","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ptr.2650090103","article-title":"Screening of Indonesian plant extracts for anti-human immunodeficiency virus\u2014type 1 (HIV-1) activity","volume":"9","author":"Otake","year":"1995","journal-title":"Phyther Res"},{"key":"10.1016\/j.jiph.2020.11.009_bib0710","unstructured":"Evaluation of Ocimum sanctum and Tinospora cordifolia as Probable HIV-Protease inhibitors | Request PDF n.d. https:\/\/www.researchgate.net\/publication\/284715195_Evaluation_of_Ocimum_sanctum_and_Tinospora_cordifolia_as_Probable_HIV-Protease_inhibitors [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0715","unstructured":"(PDF) HIV-1 reverse transcriptase inhibition by Vitex negundo L. leaf extract and quantification of flavonoids in relation to anti-HIV activity n.d. https:\/\/www.researchgate.net\/publication\/236605044_HIV-1_reverse_transcriptase_inhibition_by_Vitex_negundo_L_leaf_extract_and_quantification_of_flavonoids_in_relation_to_anti-HIV_activity [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0720","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.jiph.2020.11.009_bib0725","unstructured":"US Food and Drug Administration. 28 March 2020. Emergency use authorization, hydroxychloroquine sulfate health care provider fact sheet. U.S. Food and Drug Administration, Washington, DC. n.d. https:\/\/www.fda.gov\/media\/136534\/download [Accessed 6 October 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2020.06.001","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19","author":"Magagnoli","year":"2020","journal-title":"Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0735","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2020.11.009_bib0740","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1844","article-title":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data","author":"Mah\u00e9vas","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jiph.2020.11.009_bib0745","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0750","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0755","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0760","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0765","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 preliminary report","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with Favipiravir for COVID-19: an open-label control study","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.jiph.2020.11.009_bib0775","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2020.11.009_bib0780","unstructured":"HiNet Life n.d. https:\/\/times.hinet.net\/mobile\/ [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0785","unstructured":"Ocular Toxicity of Hydroxychloroquine - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/16912357\/ [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0790","article-title":"Hospital pharmacists\u2019 pharmaceutical care for hospitalized patients with COVID-19: recommendations and guidance from clinical experience","author":"Song","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.jiph.2020.11.009_bib0795","unstructured":"Vitamin C deployed in big doses to help treat coronavirus patients | South China Morning Post n.d. https:\/\/www.scmp.com\/news\/china\/society\/article\/3077341\/vitamin-c-deployed-big-doses-help-treat-coronavirus-patients [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.joim.2020.04.001","article-title":"Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine","author":"Wang","year":"2020","journal-title":"J Integr Med"},{"key":"10.1016\/j.jiph.2020.11.009_bib0805","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/nu12010236","article-title":"A review of micronutrients and the immune system\u2013Working in harmony to reduce the risk of infection","volume":"12","author":"Gombart","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jiph.2020.11.009_bib0810","unstructured":"Study of High-Dose Chloroquine For COVID-19 Stopped Early Due to Patient Deaths n.d. https:\/\/www.sciencealert.com\/clinical-trial-for-high-dose-of-chloroquine-stopped-early-due-to-safety-concerns [Accessed 4 June 2020]."},{"key":"10.1016\/j.jiph.2020.11.009_bib0815","unstructured":"Medicines against Coronavirus - research overview | vfa n.d. https:\/\/www.vfa.de\/de\/englische-inhalte\/therapeutic-medicines-coronavirus-covid-19 [Accessed 4 June 2020]."}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120307474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120307474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:08:36Z","timestamp":1761750516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034120307474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":163,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1876034120307474"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2020.11.009","relation":{},"ISSN":["1876-0341"],"issn-type":[{"type":"print","value":"1876-0341"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of repurposed drugs on the symptomatic COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2020.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}